Subrosa Health & Capital is a leading investment firm specializing in orphan drug and rare disease companies. With a focus on driving innovation and advancements in the field, Subrosa provides strategic capital investment, business development support, and industry expertise to help companies navigate the complex landscape of orphan drug development. Their team of experienced professionals is dedicated to fostering partnerships and accelerating the development of life-changing therapies for rare diseases. Subrosa Health & Capital is committed to making a meaningful impact in the orphan drug space and improving outcomes for patients worldwide.